Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk

202051 citationsJournal Articlebronze Open Access

Authors

H. Amarens Geuzinge · Erasmus MC

Inge-Marie Obdeijn · Erasmus MC

Emiel J. Rutgers · The Netherlands Cancer Institute

Sepideh Saadatmand · Erasmus MC

Ritse M. Mann · Radboud University Nijmegen

Jan C. Oosterwijk · University Medical Center Groningen

Rob A.�E.�M. Tollenaar ·

Abstract

This study suggests that MRI screening every 18 months between the ages of 35 and 60 years for women with a family history of breast cancer is cost-effective within the National Institute for Health and Care Excellence threshold for all densities. Higher thresholds would favor annual MRI screening. These outcomes support a change of current screening guidelines for this specific risk group and support MRI screening.

Topics & Keywords

BRCA gene mutations in cancer Global Cancer Incidence and Screening Digital Radiography and Breast Imaging

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Oncology

Volume 6, Issue 9, pp. 1381-1381

DOI: 10.1001/jamaoncol.2020.2922

Field-Weighted Citation Impact: 5.05